Cognitive remission: a novel objective for the treatment of major depression? (Q26775386)

object named as

Kamilla W Miskowiak

0 references

Brisa S Fernandes

0 references

Michael Berk

0 references

Beatrice Bortolato

0 references

Cristiano A Köhler

0 references

Michael Maes

0 references

André F Carvalho

Creative Commons Attribution 4.0 International

0 references

language of work or name

English

0 references

publication date

22 January 2016

4 references

13 March 2019

27 September 2019

21 September 2020

27 January 2021

4 references

13 March 2019

27 September 2019

21 September 2020

27 January 2021

0 references

0 references

0 references

4 references

13 March 2019

27 September 2019

21 September 2020

on focus list of Wikimedia project

27 January 2021

copyrighted

0 references

ScienceSource

0 references

cites work

Amelioration of acute sequelae of blast induced mild traumatic brain injury by N-acetyl cysteine: a double-blind, placebo controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Minocycline: therapeutic potential in psychiatry

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Mechanisms of modafinil: A review of current research

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

The Cognitive Effects of Antidepressants in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Antidepressant effects of the muscarinic cholinergic receptor antagonist scopolamine: a review

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Can noninvasive brain stimulation enhance cognition in neuropsychiatric disorders?

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

A review of current evidence for acetyl-l-carnitine in the treatment of depression

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Can transcranial direct current stimulation (tDCS) alleviate symptoms and improve cognition in psychiatric disorders?

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Disability mediates the impact of common conditions on perceived health

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

A meta-analysis of depression severity and cognitive function

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Effects of major depression on moment-in-time work performance

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Development of a Rating Scale for Primary Depressive Illness

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

A New Depression Scale Designed to be Sensitive to Change

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Modafinil for cognitive neuroenhancement in healthy non-sleep-deprived subjects: A systematic review

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Effects of omega-3 PUFA on the vitamin E and glutathione antioxidant defense system in individuals at ultra-high risk of psychosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Neurogenesis and neuroprotection in postischemic brain neurodegeneration with Alzheimer phenotype: is there a role for curcumin?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Kynurenine pathway dysfunction in the pathophysiology and treatment of depression: Evidences from animal and human studies

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Possible involvement of muscarinic receptors in psychiatric disorders: a focus on schizophrenia and mood disorders

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Effects of Erythropoietin on Hippocampal Volume and Memory in Mood Disorders

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

The relationship between neurocognitive and psychosocial functioning in major depressive disorder: a systematic review.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Cognitive dysfunction in depression - pathophysiology and novel targets

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Cognitive dysfunction in major depressive disorder: a state-of-the-art clinical review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Metformin: repurposing opportunities for cognitive and mood dysfunction

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Towards a classification of biomarkers of neuropsychiatric disease: from encompass to compass

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Vortioxetine disinhibits pyramidal cell function and enhances synaptic plasticity in the rat hippocampus

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Cognitive effects of pharmacotherapy for major depressive disorder: a systematic review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Neurocognitive predictors of antidepressant clinical response

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer's disease: a 6-month, randomized, placebo-controlled, multicenter trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Inflammation and insulin/IGF-1 resistance as the possible link between obesity and neurodegeneration

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Cognitive effects of treatment of depression with repetitive transcranial magnetic stimulation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

A meta-analysis of cognitive functions in children and adolescents with major depressive disorder

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Does duloxetine improve cognitive function independently of its antidepressant effect in patients with major depressive disorder and subjective reports of cognitive dysfunction?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

The integrative management of treatment-resistant depression: a comprehensive review and perspectives

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Statins use and risk of depression: a systematic review and meta-analysis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Sleep and sadness: exploring the relation among sleep, cognitive control, and depressive symptoms in young adults

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Recombinant human erythropoietin for treating treatment-resistant depression: a double-blind, randomized, placebo-controlled phase 2 trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Lisdexamfetamine dimesylate augmentation in adults with persistent executive dysfunction after partial or full remission of major depressive disorder

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Cognitive dysfunction in unipolar depression: implications for treatment

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Using measurement strategies to identify and monitor residual symptoms

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Acetylcholinesterase inhibitors: pharmacology and toxicology

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Association between severity of depression and self-perceived cognitive difficulties among full-time employees

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Cognitive impairment in depression: a systematic review and meta-analysis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer's disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

A randomized controlled trial of the efficacy and safety of lisdexamfetamine dimesylate as augmentation therapy in adults with residual symptoms of major depressive disorder after treatment with escitalopram

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Cognitive remediation as a treatment for major depression: A rationale, review of evidence and recommendations for future research

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Serotonergic modulation of glutamate neurotransmission as a strategy for treating depression and cognitive dysfunction

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Coenzyme Q10 depletion in medical and neuropsychiatric disorders: potential repercussions and therapeutic implications

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

The chemistry and biological activities of N-acetylcysteine

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Minocycline attenuates cognitive impairment induced by isoflurane anesthesia in aged rats

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

The epidemiology of depression across cultures

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Cognitive deficits and functional outcomes in major depressive disorder: determinants, substrates, and treatment interventions

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Relationship between markers of insulin resistance, markers of adiposity, HbA1c, and cognitive functions in a middle-aged population-based sample: the MONA LISA study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Randomized trial of minocycline in the treatment of HIV-associated cognitive impairment

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

The impact of statins on psychological wellbeing: a systematic review and meta-analysis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Effects of supplementation with n-3 polyunsaturated fatty acids on cognitive performance and cardiometabolic risk markers in healthy 51 to 72 years old subjects: a randomized controlled cross-over study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

A randomized, double-blind, controlled trial evaluating the effect of intranasal insulin on neurocognitive function in euthymic patients with bipolar disorder

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Cognitive impairment in euthymic major depressive disorder: a meta-analysis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Cognitive impairment in major depression and the mGlu2 receptor as a therapeutic target

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

The cumulative load of depressive illness is associated with cognitive function in the remitted state of unipolar depressive disorder

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Pioglitazone adjunctive therapy for moderate-to-severe major depressive disorder: randomized double-blind placebo-controlled trial.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Biology and therapeutic applications of peroxisome proliferator- activated receptors.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Effect of intranasal insulin on cognitive function: a systematic review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

A meta-analysis of cognitive deficits in first-episode Major Depressive Disorder

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Glutamatergic modulation of auditory information processing in the human brain

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Depression and type 2 diabetes: inflammatory mechanisms of a psychoneuroendocrine co-morbidity

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

A meta-analysis of executive dysfunctions in unipolar major depressive disorder without psychotic symptoms and their changes during antidepressant treatment

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Minocycline treatment for HIV-associated cognitive impairment: results from a randomized trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Use of insulin sensitizers for the treatment of major depressive disorder: a pilot study of pioglitazone for major depression accompanied by abdominal obesity

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Antidepressant use and cognitive functioning in older medical patients with major or minor depression: a prospective cohort study with database linkage

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Specifying the neuropsychology of affective disorders: clinical, demographic and neurobiological factors

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

A 35-year longitudinal assessment of cognition and midlife depression symptoms: the Vietnam Era Twin Study of Aging

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Cognitive impairment in the remitted state of unipolar depressive disorder: a systematic review.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Immune modulation of learning, memory, neural plasticity and neurogenesis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

The depression-executive dysfunction (DED) syndrome and response to antidepressants: a meta-analytic review.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Omega-3 polyunsaturated fatty acid supplementation confers long-term neuroprotection against neonatal hypoxic-ischemic brain injury through anti-inflammatory actions

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Association between depression severity and neurocognitive function in major depressive disorder: a review and synthesis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Longitudinal assessment of neuropsychological function in major depression

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Reducing suicidal ideation and depression in older primary care patients: 24-month outcomes of the PROSPECT study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Metabolic syndrome and major depressive disorder: co-occurrence and pathophysiologic overlap

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Functions of coenzyme Q10 in inflammation and gene expression

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Mitochondrial approaches for neuroprotection

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Evidence for a cytokine model of cognitive function

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Mediators of the association between depression and role functioning

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Neurocognitive correlates of response to treatment in late-life depression

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Neuropsychological characteristics as predictors of SSRI treatment response in depressed subjects

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

A double blind, placebo-controlled pilot study of galantamine augmentation of antidepressant treatment in older adults with major depression

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Augmentation strategies for treatment-resistant depression: a literature review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Thiazolidinediones: novel treatments for cognitive deficits in mood disorders?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Successful computer-assisted cognitive remediation therapy in patients with unipolar depression: a proof of principle study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Job performance deficits due to depression

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Executive function improvement upon remission of recurrent unipolar depression

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

An investigation of the neuroprotective effects of tetracycline derivatives in experimental models of retinal cell death

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Captopril and enalapril improve cognition and depressed mood in hypertensive patients.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Insulin and neurodegenerative disease: shared and specific mechanisms

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

The economic burden of depression in the United States: how did it change between 1990 and 2000?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

A prospective trial of modafinil as an adjunctive treatment of major depression

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Differences in mechanism of action between current and future antidepressants

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

S-Adenosyl-L-methionine (SAMe): from the bench to the bedside--molecular basis of a pleiotrophic molecule

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Cognitive deficits in depression: possible implications for functional neuropathology

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Safety and tolerability considerations: tricyclic antidepressants vs. selective serotonin reuptake inhibitors.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Assessment of subjective and objective cognitive function in bipolar disorder: Correlations, predictors and the relation to psychosocial function

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Fewer study participants needed to demonstrate superior antidepressant efficacy when using the Hamilton melancholia subscale (HAM-D₆) as outcome measure

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Minocycline as adjunctive therapy for patients with unipolar psychotic depression: an open-label study

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

The Factors Influencing Depression Endpoints Research (FINDER) study: final results of Italian patients with depression

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Mood and neuropsychological changes in women with midlife depression treated with escitalopram

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Effects of recurrent major depressive disorder on behavior and cognitive function in female depressed patients.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Nootropic effects of ACE inhibitors in mice.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

31 May 2018

Recovery from depression

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Cognitive impairment in unipolar depression is persistent and non-specific: further evidence for the final common pathway disorder hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

The societal cost of depression: evidence from 10,000 Swedish patients in psychiatric care

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Persistent non-verbal memory impairment in remitted major depression - caused by encoding deficits?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on memory and mental processing speed in patients with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Cognitive predictors of treatment response to bupropion and cognitive effects of bupropion in patients with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Relationships among neurocognition, symptoms, and functioning in treatment-resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Cognition as predictor of current and follow-up depressive symptoms in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Low episodic memory performance as a premorbid marker of depression: evidence from a 3-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Impairment of executive function and attention predicts onset of affective disorder in healthy high-risk twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Antidepressant drugs and the response in the placebo group: the real problem lies in our understanding of the issue

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

The empirical redefinition of the psychometric criteria for remission in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

The relationship of health-related quality of life and treatment outcome during inpatient treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Increased metabolic and cardiovascular morbidity in patients with schizophrenia: recommendation for diagnoses and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Psychomotor changes in major depressive disorder during sertraline treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Effects of sertraline on depressive symptoms and attentional and executive functions in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

The effect of bupropion XL and escitalopram on memory and functional outcomes in adults with major depressive disorder: results from a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Major Depressive Disorder in recovery and neuropsychological functioning: effects of selective serotonin reuptake inhibitor and dual inhibitor depression treatments on residual cognitive deficits in patients with Major Depressive Disorder in recover

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Psychomotor slowing as a predictor of fluoxetine nonresponse in depressed outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Executive dysfunction and long-term outcomes of geriatric depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Prefrontal neuropsychological predictors of treatment remission in late-life depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Comparative study of cognitive impairment between medicated and medication-free patients with remitted major depression: class-specific influence by tricyclic antidepressants and newer antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Evidence for continuing neuropsychological impairments in depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Is there a difference in subjective experience of cognitive function in patients with unipolar disorder versus bipolar disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Differential effects of erythropoietin on neural and cognitive measures of executive function 3 and 7 days post-administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Minocycline inhibits oxidative stress and decreases in vitro and in vivo ischemic neuronal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Treatment response and cognitive impairment in major depression: association with C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Minocycline plus N-acetylcysteine synergize to modulate inflammation and prevent cognitive and memory deficits in a rat model of mild traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome and comorbid depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Effects of S-adenosylmethionine augmentation of serotonin-reuptake inhibitor antidepressants on cognitive symptoms of major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Alpha lipoic acid: a novel treatment for depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Ethyl-eicosapentaenoic acid ingestion prevents corticosterone-mediated memory impairment induced by central administration of interleukin-1beta in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Effects of omega-3 fatty acid supplementation on mood and emotional information processing in recovered depressed individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Associations between n-3 PUFA concentrations and cognitive function after recovery from late-life depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Melatonin enhances adult rat hippocampal progenitor cell proliferation via ERK signaling pathway through melatonin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

An exploratory study of combination buspirone and melatonin SR in major depressive disorder (MDD): a possible role for neurogenesis in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Galantamine as an adjunctive treatment in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Controlled trial of N-acetylcysteine for patients with probable Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Effects of N-acetyl cysteine on cognitive function in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Curcumin for the treatment of major depression: a randomised, double-blind, placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Curcumin and major depression: a randomised, double-blind, placebo-controlled trial investigating the potential of peripheral biomarkers to predict treatment response and antidepressant mechanisms of change

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Effects of curcumin on learning and memory deficits, BDNF, and ERK protein expression in rats exposed to chronic unpredictable stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Investigation of the effects of solid lipid curcumin on cognition and mood in a healthy older population

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Simvastatin treatment exerts antidepressant-like effect in rats exposed to chronic mild stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Acute atorvastatin treatment exerts antidepressant-like effect in mice via the L-arginine-nitric oxide-cyclic guanosine monophosphate pathway and increases BDNF levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Augmentation of fluoxetine with lovastatin for treating major depressive disorder, a randomized double-blind placebo controlled-clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

In a randomized, double-blind clinical trial, adjuvant atorvastatin improved symptoms of depression and blood lipid values in patients suffering from severe major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Simvastatin as an adjuvant therapy to fluoxetine in patients with moderate to severe major depression: A double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Coenzyme Q10 displays antidepressant-like activity with reduction of hippocampal oxidative/nitrosative DNA damage in chronically stressed rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Cognition as a target in schizophrenia, bipolar disorder and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Effects of transcranial direct current stimulation on risky decision making are mediated by 'hot' and 'cold' decisions, personality, and hemisphere

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Cognitive training in affective disorders improves memory: a preliminary study using the NEAR approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0560-3

Metformin may produce antidepressant effects through improvement of cognitive function among depressed patients with diabetes mellitus

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Acute antidepressant and anxiolytic effects of simvastatin and its mechanisms in rats

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Effect of tianeptine on cognitive functions in patients with depressive disorders during a 3-month observation

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

The frequency of cognitive impairment in patients with anxiety, depression, and bipolar disorder: an unaccounted source of variance in clinical trials

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Enhancing effect of mirtazapine on cognitive functions associated with prefrontal cortex in patients with recurrent depression

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatment.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724131

Is there an association between subjective and objective measures of cognitive function in patients with affective disorders?

28 November 2018

1 reference

12 December 2020

Enduring cognitive dysfunction in unipolar major depression: a test-retest study using the Stroop paradigm

1 reference

12 December 2020

Bupropion normalizes cognitive performance in patients with depression

1 reference

12 December 2020

Executive dysfunction predicts nonresponse to fluoxetine in major depression

1 reference

12 December 2020

Statins to reduce risk of depression

1 reference

12 December 2020

Neurocognitive deficits and disability in major depressive disorder

1 reference

12 December 2020

Acetyl-L-carnitine and α-lipoic acid: possible neurotherapeutic agents for mood disorders?

1 reference

12 December 2020

Captopril-impaired production of tumor necrosis factor-alpha-induced interleukin-1beta in human monocytes is associated with altered intracellular distribution of nuclear factor-kappaB

1 reference

12 December 2020

10.1186/S12916-016-0560-3

Identifiers

DOI

1 reference

Dimensions Publication ID

1021553319

0 references

1 reference

1 reference

PubMed publication ID

26801406

1 reference